metricas
Vacunas (English Edition)
Vacunas (English Edition)
ISSN: 2445-1460

Official journal of the Asociación Española de Vacunología.

Vacunas publishes research articles related to the field of vaccine-preventable diseases in humans and those with zoonotic potential in animals. It places special emphasis on aspects associated with planning and evaluation, including the epidemiology of vaccine-preventable diseases, the development of vaccination programs, and the evaluation of the efficacy, effectiveness, and efficiency of vaccinations. It accepts articles in both Spanish and English.

The areas of interest of the journal are as follows:

    - Vaccine development and evaluation

    - Epidemiology of vaccine-preventable diseases

    - Regulatory affairs and commercial utilization and historical background of vaccines

    - Vaccine technology, vectors, adjuvants, and immunomodulators

    - Public health policies and vaccination programs

    - Vaccine immunology and mechanisms of action

    - Immunological mechanisms

    - Vaccine safety, efficacy, and effectiveness

    - Vaccine hesitancy and acceptance

    - Vaccines for chronic conditions, autoimmune diseases, allergies, and non-communicable diseases

    - Veterinary vaccines for animal health from a One Health perspective

See more Open Access Option
Indexed in:

Scopus, EMBASE/Excerpta Médica e IBECS

See more
Follow us
Subscribe
Alert
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
3.7
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.386
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
0.384
View more metrics
Hide
Issue
Cover Vol. 27. Issue 2. Vol. 27. Issue 2.
(April - June 2026)
Editorial
Vaccination in the workplace: A pending strategic agenda
José Lorenzo Bravo Grande, Carmen Muñoz Ruipérez, Teófila Vicente Herrero
Vacunas. 2026;27:
Original article
Implementation, impact of vaccination coverage and determinants of VZV immunization in people living with HIV: The HIV-ZoVax study
Silvia Ivorra-Gómez, Francisco Jover-Díaz, Teresa De Gea-Velázquez, Elisabet Delgado-Sánchez, Jorge Peris-García, Pedro Esteve-Atiénzar
Vacunas. 2026;27:
Defining the current models of immunization of immunocompromised patients in Spain, and how to improve them: results of the CARABELA-IP initiative
Jaime Pérez-Martín, Manuel García de la Vega, Gregorio Montes, Inmaculada Mediavilla, José Francisco Soto, Luciano Escudero, Marta Eva González, Victoria Nartallo, ... on behalf of the CARABELA-IP Scientific Committee
Vacunas. 2026;27:
Causality assessment of adverse events following immunization “AEFIs” linked to COVID-19 vaccines: clinical cases
Ibtissem Nour El Houda Bekhti, Derouicha Matmour, Wafaa Yakoub El Kraldia, Hadjer Larachi, Yassine Merad, Houari Toumi
Vacunas. 2026;27:
Special article
Pediatric influenza vaccination: Strategies to increase coverage
José Antonio Navarro-Alonso, Gloria Mirada-Masip, Fernando Moraga-Llop
Vacunas. 2026;27:
Review article
Impact and evolution of influenza A virus: a comprehensive review on zoonosis, animal health, and control strategies
D. Chowdhury, A. Das, M. Mishra, T. Khutere, Jayashree, R. Manna, S.H. Bodakhe
Vacunas. 2026;27:
Case report
Shingles immunization in patients under interleukin-5 inhibitor treatment
Ronald Rodríguez Cogollo, María Ángela Doronzo, Juan Gabriel Garcías Ladaria, Juan Rodríguez-García
Vacunas. 2026;27:
Vaccine strategies